Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 2.650 | 2.650 | 0.000 |
Shares | 97.350 | 97.350 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 29.969 | 24.032 |
Price to Book | 5.896 | 4.517 |
Price to Sales | 5.217 | 3.291 |
Price to Cash Flow | 20.138 | 15.892 |
Dividend Yield | 0.561 | 1.221 |
5 Years Earnings Growth | 14.956 | 12.392 |
Name | Net % | Category Average |
---|---|---|
Technology | 43.390 | 26.687 |
Healthcare | 21.470 | 16.365 |
Consumer Cyclical | 9.060 | 12.488 |
Financial Services | 7.460 | 13.478 |
Communication Services | 6.580 | 7.955 |
Industrials | 5.300 | 11.873 |
Basic Materials | 3.170 | 4.328 |
Real Estate | 2.190 | 1.947 |
Consumer Defensive | 1.390 | 8.048 |
Number of long holdings: 72
Number of short holdings: 1
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Microsoft Corp | - | 7.72 | - | - | |
NVIDIA Corp | - | 5.83 | - | - | |
Amazon.com Inc | - | 5.43 | - | - | |
Alphabet Inc Class A | - | 4.43 | - | - | |
Visa Inc Class A | - | 3.19 | - | - | |
Thermo Fisher Scientific Inc | - | 2.62 | - | - | |
Taiwan Semiconductor Manufacturing Co Ltd ADR | - | 2.61 | - | - | |
Danaher Corp | - | 2.46 | - | - | |
AstraZeneca | GB0009895292 | 2.20 | 12,118.0 | +0.56% | |
UnitedHealth Group Inc | - | 2.15 | - | - |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
BE0940002729 | 1.9B | 8.99 | 9.22 | 8.34 | ||
BE0058652646 | 2.2B | 9.27 | 4.36 | 8.66 | ||
DPAM HORIZON B Balanced Strategy B | 1.2B | 4.04 | 1.07 | 4.96 | ||
DPAM HORIZON B Balanced Strategy A | 1.2B | 4.04 | 1.29 | 5.02 | ||
BE6246061376 | 1.53B | 12.39 | 4.38 | 11.17 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review